Education
About Us
Working with TipRanks
Follow Us
GMOV - ETF AI Analysis
Top Page
GMO US Value ETF (GMOV)
Rating:73Outperform
Price Target:―
Positive Factors
Strong Top Holdings
Several key positions, such as Johnson & Johnson, Meta Platforms, and JPMorgan Chase, have delivered strong year-to-date performance, supporting the fund’s overall returns.
Sector Diversification
The ETF is spread across multiple sectors, including Financials, Health Care, and Technology, reducing the risk of overexposure to any single industry.
Reasonable Expense Ratio
The fund’s expense ratio of 0.5% is competitive for actively managed ETFs, helping investors retain more of their returns.
Negative Factors
Over-Concentration in U.S. Market
With nearly 99% of its assets in U.S. companies, the ETF lacks meaningful global diversification, exposing it to domestic market risks.
Underperforming Holdings
Some top holdings, like Merck and Pfizer, have shown negative year-to-date performance, which could drag on the fund’s overall returns.
Heavy Financial Sector Exposure
The ETF’s largest sector allocation is Financials, which could make it vulnerable to sector-specific downturns.
GMOV vs. SPDR S&P 500 ETF (SPY)
AUM69.72M
RegionNorth America
Expense Ratio0.50%
Beta0.78
IssuerGMO
Inception DateOct 28, 2024
Dividend Yield1.93%
Asset ClassEquity
Index TrackedNo Underlying Index
Share Statistics
EPS (TTM)N/A
Shares OutstandingN/A
10 Day Avg. Volume16,556
30 Day Avg. Volume18,067
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
P/FCF RatioN/A
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
31.19Price Target Upside― Downside
Rating ConsensusModerate Buy
Number of Analyst Covering166
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
GMOV Summary
The GMO US Value ETF (ticker: GMOV) is an investment fund that focuses on U.S. companies considered undervalued, meaning their stock prices may be lower than their true worth. It includes a diverse mix of sectors like financials, healthcare, and technology, with well-known companies such as Johnson & Johnson and Exxon Mobil among its top holdings. This ETF is designed for investors who want to grow their money over time by targeting stocks with strong fundamentals and potential for appreciation. However, it’s important to note that the fund’s performance can fluctuate with the overall market, and its focus on value stocks may not always align with broader market trends.
How much will it cost me?The GMO US Value ETF (GMOV) has an expense ratio of 0.5%, meaning you’ll pay $5 per year for every $1,000 invested. This is higher than average because the fund is actively managed, relying on expert analysts to select undervalued stocks with strong growth potential.
What would affect this ETF?The GMO US Value ETF could benefit from a favorable economic environment that supports undervalued stocks, particularly in sectors like Financials and Health Care, which are heavily represented in its portfolio. However, rising interest rates or regulatory changes in key sectors such as Technology and Energy could negatively impact the ETF's performance. Additionally, shifts in consumer spending or market sentiment might influence the value of top holdings like Johnson & Johnson and Meta Platforms.
GMOV Top 10 Holdings
The GMO US Value ETF leans heavily on financials and healthcare, with Johnson & Johnson and Merck providing steady support thanks to their strong fundamentals and pipeline advancements. Alphabet is rising on the back of AI and cloud growth, while Meta’s mixed performance reflects regulatory hurdles and expense concerns. Energy names like Exxon Mobil and Chevron are lagging, weighed down by revenue growth challenges. With a clear focus on U.S. value stocks, the fund’s sector diversification balances stability with growth potential, though its reliance on financials and healthcare may amplify sector-specific risks.
Name | Company Name | Weight % | Market Value | Market Cap | Yearly Gain | Overall Rating |
|---|---|---|---|---|---|---|
| Exxon Mobil | 3.78% | $2.63M | $549.07B | 16.00% | 74 Outperform | |
| Johnson & Johnson | 3.57% | $2.49M | $526.55B | 48.59% | 78 Outperform | |
| Alphabet Class A | 3.33% | $2.32M | $4.06T | 72.50% | 85 Outperform | |
| Merck & Company | 2.91% | $2.02M | $275.53B | 10.20% | 80 Outperform | |
| Meta Platforms | 2.85% | $1.98M | $1.55T | 1.55% | 76 Outperform | |
| Chevron | 2.47% | $1.72M | $336.74B | 4.25% | 71 Outperform | |
| Verizon | 2.22% | $1.55M | $167.94B | 2.66% | 81 Outperform | |
| Pfizer | 2.21% | $1.54M | $145.44B | -2.26% | 74 Outperform | |
| Bank of America | 2.20% | $1.53M | $383.23B | 12.76% | 72 Outperform | |
| Bristol-Myers Squibb | 2.15% | $1.50M | $116.08B | 0.42% | 78 Outperform |
GMOV Technical Analysis
Positive
―
Price Trends
27.12
Positive
26.65
Positive
25.42
Positive
Market Momentum
0.28
Positive
63.58
Neutral
70.60
Neutral
Evaluating momentum and price trends is crucial in ETF analysis to make informed investment decisions. For GMOV, the sentiment is Positive. The current price of undefined is equal to the 20-day moving average (MA) of 27.83, equal to the 50-day MA of 27.12, and equal to the 200-day MA of 25.42, indicating a bullish trend. The MACD of 0.28 indicates Positive momentum. The RSI at 63.58 is Neutral, neither overbought nor oversold. The STOCH value of 70.60 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for GMOV.
GMOV Peer Comparison
Comparison Results
Performance Comparison
GMOV
GMO US Value ETF
28.19
3.44
13.90%
BAMD
Brookstone Dividend Stock ETF
―
―
―
TCV
Towle Value ETF
―
―
―
GVLE
Goldman Sachs Value Opportunities ETF
―
―
―
VUSV
Vanguard Wellington U.S. Value Active ETF
―
―
―
CVAR
Cultivar ETF
―
―
―
Glossary
BuyAn ETF rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF is likely to deliver higher returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldAn ETF rated as a "Hold" s expected to perform in line with the overall market or a specific benchmark. This rating indicates that the ETF is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellAn ETF rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF may deliver lower returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst ETF Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in ETFs carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: ―
Table of Contents